We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
DHSC's Chief Commercial Officer wrote to medicine suppliers, supply chain and businesses.
DHSC's Chief Commercial Officer wrote to medicines and medical product suppliers, supply chain and businesses.
More than 600,000 people in the UK have received the first dose of the Pfizer/BioNTech COVID-19 vaccine as part of the largest vaccination programme in British history.
First published during the 2019 to 2022 Johnson Conservative government
An application for exceptional use of a COVID-19 rapid test, to be used by members of the public, has today been approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
The majority of the vaccines have been administered to the over-80s, care home workers and NHS staff through more than 70 sites across the UK.
Whilst in India, the Foreign Secretary announced that experts from India and the UK will work together on vaccines for COVID-19 and other deadly viruses.
637,379 participants from across the UK have now taken part in public health research into the effects of, and treatment for, COVID-19 in just over 8 months.
A letter from the Minister for Care to local authorities, directors of adult social services and managers of care homes for older adults.
The government is taking this precautionary step in advance of a rollout of an authorised COVID-19 vaccine and in line with other immunisation programmes.
Prime Minister Boris Johnson gave a statement at the coronavirus press conference.
The vaccine will be made available across the UK to priority groups from next week.
…The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).…
Government authorises first COVID-19 vaccine on independent advice of medicines regulator.
A technical and clinical evaluation has confirmed OptiGene RT-LAMP tests to be accurate and sensitive enough to be used for COVID-19 testing, including for those without symptoms.
The UK now has access to a total of 357 million doses of vaccines from 7 different developers.
…The government has formally asked the Medicines and Healthcare products Regulatory Agency to evaluate whether supply of Oxford/AstraZeneca vaccine can be authorised.…
UK’s independent regulator to evaluate latest data from Pfizer and BioNTech to ensure the quality, safety and effectiveness of the vaccine meets the standards required.
Vaccine could be delivered to the UK from Spring 2021.
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
We are reviewing the risks and benefits of the acne medicine, isotretinoin. In particular whether some of the possible psychiatric and sexual side effects continue after treatment has been stopped.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).